Get the Stockscreener App
2.09
6.28%
-0.14
After Hours:
2.09
Omniab Inc stock is traded at $2.09, with a volume of 639.93K.
It is down -6.28% in the last 24 hours and down -37.61% over the past month.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
See More
Previous Close:
$2.23
Open:
$2.15
24h Volume:
639.93K
Relative Volume:
1.05
Market Cap:
$255.26M
Revenue:
$34.16M
Net Income/Loss:
$-50.62M
P/E Ratio:
-4.1142
EPS:
-0.508
Net Cash Flow:
$703.00K
1W Performance:
-13.64%
1M Performance:
-37.61%
6M Performance:
-47.62%
1Y Performance:
-60.93%
1-Day Range:
$2.01
$2.20
1-Week Range:
$2.01
$2.425
52-Week Range:
$2.01
$5.45
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
2.09 | 255.26M | 34.16M | -50.62M | 703.00K | -0.508 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
RBC Capital Sticks to Their Buy Rating for OmniAb (OABI) - The Globe and Mail
OmniAb CFO Kurt Gustafson sells $28,352 in common stock - Investing.com
OmniAb CFO Kurt Gustafson sells $28,352 in common stock By Investing.com - Investing.com South Africa
OmniAb, Inc. (NASDAQ:OABI) Shares Sold by Swiss National Bank - Defense World
Analyst Forecasts Just Became More Bearish On OmniAb, Inc. (NASDAQ:OABI) - Yahoo
Royal Bank of Canada Lowers OmniAb (NASDAQ:OABI) Price Target to $4.00 - Defense World
Charles Schwab Investment Management Inc. Has $2.90 Million Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
RBC Cuts Price Target on OmniAb to $4 From $7, Keeps Outperform Rating - MarketScreener
Bank of New York Mellon Corp Sells 63,047 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb : March 2025 Corporate Overview -March 24, 2025 at 04:08 pm EDT - Marketscreener.com
OmniAb price target lowered to $4 from $8 at TD Cowen - MSN
Equities Analysts Set Expectations for OmniAb Q1 Earnings - Defense World
Analysts Maintain Strong Buy Rating for OmniAb Stock (OABI) Despite Price Decline - markets.businessinsider.com
OmniAb director John L. Higgins acquires $9,120 in common stock By Investing.com - Investing.com Australia
OmniAb, Inc. (NASDAQ:OABI) Q4 2024 Earnings Call Transcript - Insider Monkey
Benchmark Has Lowered Expectations for OmniAb (NASDAQ:OABI) Stock Price - Defense World
Leerink Partnrs Has Weak Outlook for OmniAb FY2025 Earnings - Defense World
Q4 Earnings Forecast for OmniAb Issued By HC Wainwright - Defense World
Director John Higgins Acquires 125,750 Shares of OmniAb Inc (OAB - GuruFocus
OmniAb’s Earnings Call: Growth Amid Challenges - TipRanks
OmniAb director John L. Higgins acquires $9,120 in common stock - Investing.com
OmniAb’s Strategic Growth and Financial Management Drive Buy Rating - TipRanks
HC Wainwright Reaffirms Buy Rating for OmniAb (NASDAQ:OABI) - Defense World
OmniAb Inc (OABI): At $2.44, It’s Worth Your Attention - Stocks Register
OmniAb director John L. Higgins purchases $295,512 in common stock By Investing.com - Investing.com South Africa
OmniAb director John L. Higgins purchases $295,512 in common stock - Investing.com
Benchmark cuts OmniAb stock price target to $6, maintains Buy By Investing.com - Investing.com Canada
Benchmark cuts OmniAb stock price target to $6, maintains Buy - Investing.com
OmniAb Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OmniAb shares surge as Q4 revenue more than doubles - Investing.com India
OmniAb Reports 2024 Financial Results and Strategic Growth - TipRanks
Earnings call transcript: OmniAb Q4 2024 sees revenue jump, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: OmniAb Q4 2024 sees revenue jump, stock dips - Investing.com UK
OmniAb, Inc. (OABI) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
OmniAb shares surge as Q4 revenue more than doubles By Investing.com - Investing.com South Africa
OmniAb, Inc. SEC 10-K Report - TradingView
OmniAb Q4 Loss Narrows, Revenue Up; Issues Outlook -March 18, 2025 at 05:02 pm EDT - Marketscreener.com
OmniAb Inc reports results for the quarter ended December 31Earnings Summary - TradingView
OmniAb Inc (OABI) Q4 Earnings: Revenue Beats at $10.8M, EPS Misses at -$0.12 - GuruFocus.com
OMNIAB Earnings Results: $OABI Reports Quarterly Earnings - Nasdaq
OmniAb : 4Q24 Earnings Presentation -March 18, 2025 at 04:19 pm EDT - Marketscreener.com
OmniAb reports Q4 EPS (12c), consensus (10c) - TipRanks
OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Business Wire
OmniAb (OABI) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Rhumbline Advisers Sells 19,829 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
Chiome Bioscience and OmniAb Collaborate on Antibody Research - TipRanks
OmniAb to Report Fourth Quarter 2024 Financial Results on March 18 - Business Wire
OmniAb, Inc. (NASDAQ:OABI) Insider Charles S. Berkman Sells 8,215 Shares - MarketBeat
OmniAb, Inc. (NASDAQ:OABI) CEO Sells $51,387.52 in Stock - MarketBeat
Omniab CFO Kurt Gustafson sells shares worth $26,625 - Investing.com India
Omniab CFO Kurt Gustafson sells shares worth $26,625 By Investing.com - Investing.com Nigeria
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):